Evaluation of the GORE TIGRIS Vascular Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.

Also called NCT01576055

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 267 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01576055
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01576055. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2016-10-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the GORE TIGRIS Vascular Stent
Acronym
TIGRIS
Condition
Peripheral Arterial Disease
Intervention (Device)
TIGRIS Vascular Stent
Intervention (Device)
BARD LifeStent
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct01576055
Content hash
c2207772a682ba36d246fbd4877bd7f5b65810422348bd8901138534d375f582